Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Those who took the drug, which is included in Zepatier (grazoprevir/elbasvir), had a low rate of liver cancer during the following years.
Half of people with worse liver function responded well to immunotherapy.
Whether such recurrence is less likely after interferon treatment remains the source of some controversy in the hep C research community.
Liver fat may be a driver of increased cancer risk associated with obesity.
A second immunotherapy option is now available for hepatocellular carcinoma.
Investigators have found biomarkers that might one day be used to help detect liver cancer during earlier stages.
Scientists aren’t sure, but they know that the risk that a previous case of liver cancer will return remains high for those cured of hep C.
Although the risk is low, periodic medical monitoring for liver cancer among those with hepatitis B surface antigen clearance is advised.
Researchers analyzed a cohort of South Koreans taking Viread (tenofovir disoproxil fumarate) or Baraclude (entecavir) for hepatitis B.
According to the National Cancer Institute, liver cancer is the fifth leading cause of cancer death in the United States.
Researchers looked both at the first and second time people with HIV have been diagnosed with cancer.
When someone you love has a liver transplant, you go through it too. You’re the caregiver, the support and a liver disease warrior too.
Hep C Patient John continues to share his conquering story of his post liver transplant experience.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.